Showing results (231-240 of 782) with videos related to

Sort By:
Pageof 79
The European Physical Journal. E, Soft Matter|February 28, 2008
Intrusion of fluids into nanogrooves: how geometry determines the shape of the gas-liquid interfaceH Bohlen, A O Parry, E Díaz-Herrera, et al.
Frontiers in Neuroanatomy|July 2, 2014
Post-mortem magnetic resonance microscopy (MRM) of the murine brain at 7 Tesla results in a gain of resolution as compared to in vivo MRMOliver von Bohlen Und Halbach, Martin Lotze, Jörg P Pfannmöller
Annals of Hematology|May 10, 2000
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's diseaseH Bohlen, M Kessler, M Sextro, et al.
Fresenius' Journal of Analytical Chemistry|August 11, 2001
Development of a procedure for the multi-element determination of trace elements in wine by ICP-MSM M Castiñeira, R Brandt, A von Bohlen, et al.
Frontiers in Neuroanatomy|October 18, 2019
Transduction of Craniofacial Motoneurons Following Intramuscular Injections of Canine Adenovirus Type-2 (CAV-2) in Rhesus MacaquesMartin O Bohlen, Hala G El-Nahal, Marc A Sommer
Scientific Reports|September 27, 2022
Compact all-optical precision-tunable narrowband hard Compton X-ray sourceT Brümmer, S Bohlen, F Grüner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 16, 2013
Differentiation of cerebral representation of occlusion and swallowing with fMRIPaul G Mihai, Oliver von Bohlen Und Halbach, Martin Lotze
Nanoscale|May 19, 2022
Salt-induced conformational switching of a flat rectangular DNA origami structureKristina Hübner, Mario Raab, Johann Bohlen, et al.
The European Journal of Neuroscience|July 4, 2020
Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson's diseaseCynthia Moore, Mo Xu, Jerry K Bohlen, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphomaO Manzke, S Titzer, H Tesch, et al.
Pageof 79